Paul Josephs

CIK: 0002022547

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

$LIFECORE BIOMEDICAL, INC. \DE\ logo$

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
May 20, 2026
Tax Payment(F)
Direct
40.4K shares at avg. $4.57$185K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Jul 8, 2025
Exercise(M)
Direct
150K shares-
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Jul 8, 2025
Tax Payment(F)
Direct
54.9K shares at avg. $8.19$449K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
May 20, 2025
Tax Payment(F)
Direct
21.5K shares at avg. $6.63$143K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Jan 8, 2025
Purchase(P)
Direct
17K shares at avg. $5.74$98K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Dec 6, 2024
Tax Payment(F)
Direct
11.8K shares at avg. $7.15$84K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Dec 6, 2024
Award(A)
Direct
38.5K shares-

		Type	Shares	Price		Ownership
May 20, 2026	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	40,413	$4.57	$184,687	Direct
Jul 8, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Exercise(M)	150,000	-	-	Direct
Jul 8, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	54,857	$8.19	$449,279	Direct
May 20, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	21,532	$6.63	$142,757	Direct
Jan 8, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Purchase(P)	17,000	$5.74	$97,580	Direct
Dec 6, 2024	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	11,769	$7.15	$84,148	Direct
Dec 6, 2024	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Award(A)	38,461	-	$0	Direct

1-7 of 7 transactions

About Josephs Paul

Josephs Paul (SEC CIK 0002022547) files insider reports with the SEC as Chief Executive Officer of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).

Signal8 holds 5 ownership filings by Josephs Paul, all Form 4s, filed between Dec 10, 2024 and May 21, 2026. Those filings report 7 transactions, from Dec 6, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Josephs Paul's filings is in CHASKA, MN.

Recent filings by Josephs Paul

May 20, 2026: Tax withholding of LFCR shares (Form 4, code F).
Jul 8, 2025: Option exercise of LFCR shares (Form 4, code M).
Jul 8, 2025: Tax withholding of LFCR shares (Form 4, code F).
May 20, 2025: Tax withholding of LFCR shares (Form 4, code F).
Jan 8, 2025: Open-market purchase of LFCR shares (Form 4, code P).

Other insiders filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

How to read Form 4 transaction codes